New Data Debunks Cat Food Myths with Veterinary Support on International Cat Day
According to a Mars Pet Parent Survey, 43% of Indian cat owners consider their cats "the most important part of their lives," highlighting the growing need for proper pet care education. This year's International Cat Day theme, #CatFriendlyEveryDay, focuses on precisely this—understanding a cat's needs, which includes their diet, to ensure their well-being.
To understand the perspectives of pet nutrition and the gap that exists in the feeding practices across pets, we interviewed more than 500 veterinarians across India. We utilized both quantitative and qualitative research methods to analyze their views on pet parent awareness, current feeding practices, and common myths, allowing us to gain key insights." said Pankaj Jha (Co-founder, EVAL360 Research and Advisory Services).
Cats' digestive physiology is different from humans in handling food or nutrient requirements. Many foods that are fine for humans can cause stomach problems, or serious health issues in them. Our food including vegetarian food can cause inadequate or malnutrition while raw meat/ eggs , garlic or onion, chocolates or grapes can lead to health issues or toxicity. It may be tempting to share our food with cats but their bodies need special diets to stay healthy. Feeding an unbalanced or inadequate diet causes several health issues affecting skin and coat , oral health and digestive health as well as obesity related health problems. Cat parents should provide balanced pet food and check with a vet before giving them any human food. Keeping pets on the right diet is one of the best ways to show love and care.' said, Dr Umesh Kallahali, Small Animal Consultant, Mars Petcare'.
Debunking Common Cat Food Myths
The survey directly addresses several widespread myths about cat nutrition, providing a clear, fact-based guide for pet parents
Myth: People think that milk should be given to cats. But this is a myth, adult cats don't have enzymes to digest lactose
Most cats are lactose intolerant and cannot properly digest milk. Dr. Saurabh Kumar (Lucknow) said: 'People think that milk should be given to cats. But this is a myth. The reason for not providing milk to adult cats is that they don't have the enzymes to digest lactose.'
Myth: Homemade food is always better or sufficient for a pet's nutritional needs.
88% of vets say home-cooked food does not meet a cat's nutritional needs. Dr. Saloni Mishra (Jaipur) said, 'Cats require essential nutrients like amino acids (L-carnitine and Taurine, especially for cats) and vital minerals like zinc, selenium, copper, and omega-3 fatty acids that aid a healthy coat, skin, and immune system for the Indian scenario."
Myth: Commercial pet foods are harmful and cause health issues like allergies or seizures.
The study reveals vets observe significant health improvements when pets switch from home-cooked to nutritionally complete packaged food. 70% of vets reported weight control, 66% observed increased energy, and 61% noted fewer digestive issues.
Myth: Packaged pet food is like "junk food" for humans or made from inferior by-products.
Veterinarians highlight the scientific advantages of packaged pet food over home-cooked food. A remarkable 91% of vets feel that nutrient balance and calorie precision are key scientific benefits, and 79% point to safety, quality, and digestibility. Experts note that globally manufactured pet foods are "research based" and provide nutrients in appropriate proportions missing in homemade options.
Veterinarians recommend feeding cats scientifically balanced, complete diets that meet their life stage, breed, and health needs. If home-cooked meals are preferred, pet parents must ensure these are vet-guided and supplemented appropriately. Above all, they should stop treating cats like small humans—and start feeding them like cats.
This International Cat Day, let's go beyond cuddles and care, let's feed with facts.
Note to readers: This article is part of HT's paid consumer connect initiative and is independently created by the brand. HT assumes no editorial responsibility for the content, including its accuracy, completeness, or any errors or omissions. Readers are advised to verify all information independently.
Want to get your story featured as above? click here!
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
2 hours ago
- India Today
Research explores how social support shapes health awareness
The research, accepted for publication in the Journal of Marketing, offers a groundbreaking insight: who delivers what message about cervical cancer screening matters. In 2024, cervical cancer claimed 80,000 lives in India, nearly a quarter of the global toll. Yet almost all of these deaths were preventable. Why are so many Indian women still dying from cervical cancer? The answer lies not in our hospitals, but in our homes, communities, and deep-rooted cultural norms. The research, accepted for publication in the Journal of Marketing, offers a groundbreaking insight: who delivers what message about cervical cancer screening matters. THE REAL BARRIERS TO SCREENING As per the NFHS-5, only 1.9% of Indian women undergo cervical cancer screening (CCS), compared to over 70% in countries like Australia. Government campaigns rely heavily on posters and infographics warning of cervical cancer's dangers. While well-meaning, these tactics assume one key thing: that women are free to act on this information. The reality, as our study shows, is far more complex. Working across four Indian states, we found that two significant barriers stand in the way of CCS adoption: lack of awareness and disempowering sociocultural norms. Many women simply do not know what cervical cancer is or why they should get screened. More troubling, even when aware, fear, stigma, and dependence on male family members often stop women from seeking help. But there's hope, and it doesn't require expensive technology or a new infrastructure. Instead, it calls for rethinking who we empower to speak. DOCTORS VS PEERS: WHO DO WOMAN LISTEN TO? We ran large-scale field experiments comparing different messengers and messaging styles. Unsurprisingly, doctors were trusted and credible. When doctors delivered factual information about cervical cancer, its risks, symptoms, and treatments, women responded more favourably than they did to impersonal infographics. However, the real breakthrough came when the message was delivered by a peer, another woman from the same community, using a tone of empowerment rather than fear. When local women shared stories that normalised CCS, addressed common taboos, and encouraged others to take control of their health, the impact was transformative. The study showed that peer-delivered empowering messages were the right fit to persuade, leading to a 36.5% increase in screening adoption compared to standard methods. That's 21 million additional Indian women potentially getting screened, an enormous win for public health. EMPOWERMENT OVER FEAR Why does this work? Because women listen to women they relate to. When a neighbor shares that she went for a screening and is now encouraging others to do the same, it's not just a health message; it's social permission. It breaks the silence, eases fears, and creates a ripple effect of trust. This doesn't mean doctors aren't important. Their involvement still significantly boosts perceived value and willingness to pay for services. But when it comes to changing behaviour, peers are often better placed to overcome stigma and cultural resistance, especially when they deliver messages that empower rather than scare. WHAT INDIA MUST DO NEXT This insight has powerful implications for public health strategy. Here's what India can do: Rethink public health campaigns: Replace faceless posters and expert-heavy materials with real women from the community telling their stories in their own words. Train peer educators: Equip local health workers, ASHAs, and community leaders not just with facts but with tools to talk about screening in ways that resonate with women's daily lives and concerns. The tools do not have to be expensive. In our research, we used simple WhatsApp videos of messages from a female doctor and a female peer. Empower women to empower each other: Normalise conversations about reproductive health in women's self-help groups, anganwadi centers, and everyday settings like community kitchens or village meetings. Involve civil society: NGOs that already have deep community ties can be pivotal in scaling peer-led interventions. Camp based screenings by NGOs with clear referral pathways can be particularly effective. This isn't just about saving lives. It's about reclaiming agency for millions of Indian women. It's about shifting the healthcare narrative from 'you should do this' to 'let's do this together.' The fight against cervical cancer won't be won in labs, clinics or lecture halls, it will be won in kitchens, community halls, and farm fields. By recognising the power of peer influence and contextualising our health messages to women's lived experiences, India has the chance to move from awareness to action, and from silence to survival. (THIS ARTICLE HAS BEEN PUBLISHED WITH THE PERMISSION OF IIM UDAIPUR. THE VIEWS AND OPINIONS EXPRESSED IN THIS ARTICLE ARE SOLELY THOSE OF THE AUTHOR AND DO NOT NECESSARILY REFLECT THE VIEWS OF INDIA TODAY) In 2024, cervical cancer claimed 80,000 lives in India, nearly a quarter of the global toll. Yet almost all of these deaths were preventable. Why are so many Indian women still dying from cervical cancer? The answer lies not in our hospitals, but in our homes, communities, and deep-rooted cultural norms. The research, accepted for publication in the Journal of Marketing, offers a groundbreaking insight: who delivers what message about cervical cancer screening matters. THE REAL BARRIERS TO SCREENING As per the NFHS-5, only 1.9% of Indian women undergo cervical cancer screening (CCS), compared to over 70% in countries like Australia. Government campaigns rely heavily on posters and infographics warning of cervical cancer's dangers. While well-meaning, these tactics assume one key thing: that women are free to act on this information. The reality, as our study shows, is far more complex. Working across four Indian states, we found that two significant barriers stand in the way of CCS adoption: lack of awareness and disempowering sociocultural norms. Many women simply do not know what cervical cancer is or why they should get screened. More troubling, even when aware, fear, stigma, and dependence on male family members often stop women from seeking help. But there's hope, and it doesn't require expensive technology or a new infrastructure. Instead, it calls for rethinking who we empower to speak. DOCTORS VS PEERS: WHO DO WOMAN LISTEN TO? We ran large-scale field experiments comparing different messengers and messaging styles. Unsurprisingly, doctors were trusted and credible. When doctors delivered factual information about cervical cancer, its risks, symptoms, and treatments, women responded more favourably than they did to impersonal infographics. However, the real breakthrough came when the message was delivered by a peer, another woman from the same community, using a tone of empowerment rather than fear. When local women shared stories that normalised CCS, addressed common taboos, and encouraged others to take control of their health, the impact was transformative. The study showed that peer-delivered empowering messages were the right fit to persuade, leading to a 36.5% increase in screening adoption compared to standard methods. That's 21 million additional Indian women potentially getting screened, an enormous win for public health. EMPOWERMENT OVER FEAR Why does this work? Because women listen to women they relate to. When a neighbor shares that she went for a screening and is now encouraging others to do the same, it's not just a health message; it's social permission. It breaks the silence, eases fears, and creates a ripple effect of trust. This doesn't mean doctors aren't important. Their involvement still significantly boosts perceived value and willingness to pay for services. But when it comes to changing behaviour, peers are often better placed to overcome stigma and cultural resistance, especially when they deliver messages that empower rather than scare. WHAT INDIA MUST DO NEXT This insight has powerful implications for public health strategy. Here's what India can do: Rethink public health campaigns: Replace faceless posters and expert-heavy materials with real women from the community telling their stories in their own words. Train peer educators: Equip local health workers, ASHAs, and community leaders not just with facts but with tools to talk about screening in ways that resonate with women's daily lives and concerns. The tools do not have to be expensive. In our research, we used simple WhatsApp videos of messages from a female doctor and a female peer. Empower women to empower each other: Normalise conversations about reproductive health in women's self-help groups, anganwadi centers, and everyday settings like community kitchens or village meetings. Involve civil society: NGOs that already have deep community ties can be pivotal in scaling peer-led interventions. Camp based screenings by NGOs with clear referral pathways can be particularly effective. This isn't just about saving lives. It's about reclaiming agency for millions of Indian women. It's about shifting the healthcare narrative from 'you should do this' to 'let's do this together.' The fight against cervical cancer won't be won in labs, clinics or lecture halls, it will be won in kitchens, community halls, and farm fields. By recognising the power of peer influence and contextualising our health messages to women's lived experiences, India has the chance to move from awareness to action, and from silence to survival. (THIS ARTICLE HAS BEEN PUBLISHED WITH THE PERMISSION OF IIM UDAIPUR. THE VIEWS AND OPINIONS EXPRESSED IN THIS ARTICLE ARE SOLELY THOSE OF THE AUTHOR AND DO NOT NECESSARILY REFLECT THE VIEWS OF INDIA TODAY) Join our WhatsApp Channel
The Hindu
2 hours ago
- The Hindu
AINU launches new centre in Hyderabad covering various sub-specialities
The Asian Institute of Nephrology and Urology (AINU), launched its new centre in Banjara Hills here on Monday. The hospital has a capacity of 150 beds. The centre features four operating rooms, 34 dialysis stations and advanced robotic surgical technology, enabling complex urology and nephrology procedures with greater precision. The hospital also has eight centres of excellence, covering sub-specialities such as female urology, uro-oncology and robotic surgery, paediatric urology, reconstructive urology and andrology. The burden of urological diseases is rising sharply in India due to lifestyle disorders such as hypertension, obesity and diabetes, coupled with increased life expectancy. 'Prostate cancer is now the second most common cancer among Indian men, growing at 2.5% annually, and 50 to 60% of men over 60 suffer from benign prostatic enlargement,' said AINU manging director Mallikarjuna. He added that 25 years ago, urology was largely limited to treating kidney stones and enlarged prostates. Today, the scope includes advanced cancer care, complex reconstructions, paediatric interventions, female urology and robotic surgeries. 'One doctor cannot be perfect in every area, so we have created dedicated teams focused solely on one sub-speciality, performing the same surgeries repeatedly. This results in faster procedures, fewer complications, better outcomes and ultimately lower costs for patients,' he added.
Economic Times
3 hours ago
- Economic Times
India clears Roche's 7-minute cancer injection Tecentriq for patients, with Phase IV trial condition
Synopsis Roche has received clearance to import and market Atezolizumab injection (Tecentriq) for subcutaneous administration in India, potentially reducing cancer treatment time and costs. The approval, granted by a technical committee, requires Roche to conduct a Phase IV clinical trial in India. This new route offers a faster, more convenient option for patients, with administration possible outside of hospitals. Roche Gets Approval to Import Key Cancer Injection for Domestic Mkt New Delhi: The technical committee constituted for supervising clinical trials on new chemical entities has cleared Swiss drug major Roche to import and market cancer drug Atezolizumab injection (Tecentriq) through subcutaneous (SC) route-under the skin injection for Indian decisions is expected to provide relief to patients in the contry as the new subcutaneous injections will cut treatment time to nearly seven minutes from the 30-60 minutes in the standard intravenous (IV) infusion, besides saving on costs. The panel's permission has been given with a condition that the company would conduct a Phase IV clinical trial in India. "Switching from intravenous (IV) to subcutaneous (SC) administration of Atezolizumab can potentially reduce costs due to decreased healthcare professional time and improved patient convenience," a government official told ET. "Tecentriq may be administered by a healthcare professional outside of the hospital, in a community care setting or at a patient's home," he added. Atezolizumab is an immunotherapy called an immune checkpoint inhibitor, which blocks the immune system's natural brakes to help immune cells fight technical committee under the Director General of Health Services (DGHS) was formed in 2013 following the directions of the Supreme a recent meeting, Roche presented the proposal for grant of permission to import and market the drug product Atezolizumab injection (Tecentriq®) 1875 mg/15 mL vial for subcutaneous administration for the following indications with the request of local Phase III clinical trial waiver and commitment to conduct a Phase IV trial in is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy. It is a monotherapy for the first line treatment of patients of metastatic committee noted the pharmacokinetic-pharmacodynamic or PK/PD results of Asian & non-Asian population from the global clinical study for the ethnic differences in the PK parameters in the study. The committee further noted that firm has received the USFDA approval for the SC route on committee also asked the company to submit Phase IV clinical trial protocol to CDSCO within three months of grant of marketing authorisation.
